Strand AI
Multimodal foundation models to predict uncollected patient biology
About
Strand AI develops foundation models to generate missing bio-data about patients. With this imputed data, pharmaceutical companies can select better patients for their drug trials and shave months from their drug launch timelines. We’ve already trained a multimodal foundation model that integrates spatial biology modalities, beating SOTA at a fraction of the cost.
Topics
HealthcareDrug Discovery and Delivery
- Location
- San Francisco, CA, United States
- Team size
- 2 employees
- YC batch
- Winter 2026
- Status
- Active
- Stage
- Early stage
